CordovaCann (LVRLF) AI Stock Analysis
CordovaCann
(Other OTC:LVRLF)
No summary available
CordovaCann (LVRLF) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $3.29M
- Dividend Yield
- ―
- Average Volume (3M)
- 28.95K
- Price to Earnings (P/E)
- -1.0
- Beta (1Y)
- -1.79
- Revenue Growth
- -5.45%
- EPS Growth
- 44.32%
- Country
- US
- Employees
- 45
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
CordovaCann Business Overview & Revenue Model
Company Description
CordovaCann Corp. is a company that focuses on various aspects of the cannabis industry, including identifying prospects, securing financing, developing new ventures, and managing operations throughout the entire cannabis value chain. As of February...
CordovaCann Risk Analysis
CordovaCann disclosed 43 risk factors in its most recent earnings report. CordovaCann reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksCordovaCann Peers Comparison
Overall Rating
TSE:BBM45Neutral
TSE:CVGR41Neutral
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| LVRLF | CordovaCann Corp | 0.03 | 0.01 | 38.10% | |
| TSE:BBM | Blueberries Medical | 0.01 | -0.01 | -25.00% | |
| TSE:BAMM | Body & Mind | 0.03 | 0.00 | 0.00% | |
| TSE:CVGR | City View Green Holdings, Inc. | 0.03 | -0.04 | -53.85% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.